These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
494 related articles for article (PubMed ID: 16468325)
21. A patient with myelodysplastic syndrome studied by GTG-banding and fluorescent in situ hybridization (FISH). Mark HF; Mark Y; Sotomayor E; Sambandam S Cytobios; 1998; 94(376):121-8. PubMed ID: 9839434 [TBL] [Abstract][Full Text] [Related]
22. [The value of multiplex fluorescence in situ hybridization in the detection of complex karyotypic abnormalities of acute myeloid leukemia]. Ma L; Li JY; Pan JL; Xiao B; Qian SX; Chen LJ; Qiu HR; Wen BZ; Xue YQ Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):318-22. PubMed ID: 16875581 [TBL] [Abstract][Full Text] [Related]
23. Fluorescence in situ hybridization testing for -5/5q, -7/7q, +8, and del(20q) in primary myelodysplastic syndrome correlates with conventional cytogenetics in the setting of an adequate study. Pitchford CW; Hettinga AC; Reichard KK Am J Clin Pathol; 2010 Feb; 133(2):260-4. PubMed ID: 20093235 [TBL] [Abstract][Full Text] [Related]
24. Cytogenetic features of 5q deletion and 5q- syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization. Lee HR; Oh B; Hong DS; Zang DY; Yoon HJ; Kim HJ; Kim I; Ahn JS; Cheong JW; Lee KA; Cho KS; Lee MH; Bang SM; Kim TY; Yun YM; Min YH; Lee YK; Lee DS; Cancer Genet Cytogenet; 2010 Dec; 203(2):193-202. PubMed ID: 21156233 [TBL] [Abstract][Full Text] [Related]
25. Centromeric breakage and highly rearranged chromosome derivatives associated with mutations of TP53 are common in therapy-related MDS and AML after therapy with alkylating agents: an M-FISH study. Andersen MK; Christiansen DH; Pedersen-Bjergaard J Genes Chromosomes Cancer; 2005 Apr; 42(4):358-71. PubMed ID: 15645489 [TBL] [Abstract][Full Text] [Related]
26. [Detection of -5/5q- chromosome abnormality in myelodysplastic syndromes by interphase fluorescence in situ hybridization]. Shen Y; Xue Y; Li J Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):517-9. PubMed ID: 11769675 [TBL] [Abstract][Full Text] [Related]
27. [Identification of complex chromosomal aberrations in acute leukemia by using conventional cytogenetics combined with multiplex fluorescence in situ hybridization]. Yu F; Li CW; Wei H; Liu XP; Lin D; Gong JY; Qin S; Xu FY; Mi YC; Wang JX Zhonghua Xue Ye Xue Za Zhi; 2010 May; 31(5):289-93. PubMed ID: 21122305 [TBL] [Abstract][Full Text] [Related]
28. Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia. Trost D; Hildebrandt B; Beier M; Müller N; Germing U; Royer-Pokora B Cancer Genet Cytogenet; 2006 Feb; 165(1):51-63. PubMed ID: 16490597 [TBL] [Abstract][Full Text] [Related]
29. Structural aberrations of chromosome 7 revealed by a combination of molecular cytogenetic techniques in myeloid malignancies. Brezinová J; Zemanová Z; Ransdorfová S; Pavlistová L; Babická L; Housková L; Melichercíková J; Sisková M; Cermák J; Michalová K Cancer Genet Cytogenet; 2007 Feb; 173(1):10-6. PubMed ID: 17284364 [TBL] [Abstract][Full Text] [Related]
30. Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotyping. Odero MD; Carlson K; Calasanz MJ; Lahortiga I; Chinwalla V; Rowley JD Genes Chromosomes Cancer; 2001 Jun; 31(2):134-42. PubMed ID: 11319801 [TBL] [Abstract][Full Text] [Related]
31. Identification of a subtle t(16;19)(p13.3;p13.3) in an infant with multiple congenital abnormalities using a 12-colour multiplex FISH telomere assay, M-TEL. Brown J; Horsley SW; Jung C; Saracoglu K; Janssen B; Brough M; Daschner M; Beedgen B; Kerkhoffs G; Eils R; Harris PC; Jauch A; Kearney L Eur J Hum Genet; 2000 Dec; 8(12):903-10. PubMed ID: 11175277 [TBL] [Abstract][Full Text] [Related]
32. A der(13)t(7;13)(p13;q14) with monoallelic loss of RB1 and D13S319 in myelodysplastic syndrome. Yamamoto K; Ito M; Minagawa K; Urahama N; Sada A; Okamura A; Matsui T Cancer Genet Cytogenet; 2005 Oct; 162(2):160-5. PubMed ID: 16213365 [TBL] [Abstract][Full Text] [Related]
33. Clinical and experimental study of two cases of myelodysplastic syndrome with t(3; 5) (q25; q34) translocation. Wu Y; Xue Y; Zhao M; Chen S; Pan J; Lu D Zhonghua Xue Ye Xue Za Zhi; 2002 Jun; 23(6):304-6. PubMed ID: 12411061 [TBL] [Abstract][Full Text] [Related]
34. Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent overrepresentation of 21q, 11q, and 22q. Mrózek K; Heinonen K; Theil KS; Bloomfield CD Genes Chromosomes Cancer; 2002 Jun; 34(2):137-53. PubMed ID: 11979548 [TBL] [Abstract][Full Text] [Related]
35. Cytogenetic profile of myelodysplastic syndromes with complex karyotypes: an analysis using spectral karyotyping. Martínez-Ramírez A; Urioste M; Alvarez S; Vizmanos JL; Calasanz MJ; Cigudosa JC; Benítez J Cancer Genet Cytogenet; 2004 Aug; 153(1):39-47. PubMed ID: 15325092 [TBL] [Abstract][Full Text] [Related]
36. Cytogenetics and fluorescence in-situ hybridization in detection of hematological malignancies. Frenny VJ; Antonella Z; Luisa A; Shah AD; Sheth JJ; Rocchi M Indian J Cancer; 2003; 40(4):135-9. PubMed ID: 14716109 [TBL] [Abstract][Full Text] [Related]
37. Detection of complex karyotype in a myelodysplastic syndrome cell line (MUTZ-1) by metaphase fluorescence in situ hybridization. Chen BA; Xia GH; Li JY; Xiao B; Shao ZY; Chen NN; Gao C; Wu YJ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):46-9. PubMed ID: 16584590 [TBL] [Abstract][Full Text] [Related]